S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
South Korean doctors hold massive anti-government rally over medical school recruitment plan
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
South Korean doctors hold massive anti-government rally over medical school recruitment plan
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
South Korean doctors hold massive anti-government rally over medical school recruitment plan
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
South Korean doctors hold massive anti-government rally over medical school recruitment plan
NASDAQ:CPIX

Cumberland Pharmaceuticals (CPIX) Stock Price, News & Analysis

$2.12
-0.01 (-0.47%)
(As of 03/1/2024 ET)
Today's Range
$2.12
$2.21
50-Day Range
$1.74
$2.24
52-Week Range
$1.43
$2.56
Volume
7,339 shs
Average Volume
9,056 shs
Market Capitalization
$31.59 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

CPIX stock logo

About Cumberland Pharmaceuticals Stock (NASDAQ:CPIX)

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It also develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases; and a product candidate for cholesterol reducing agent to use in the hospital setting. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.

CPIX Stock Price History

CPIX Stock News Headlines

This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Senior Living Communities Near New Cumberland, PA
Assisted Living Communities Near New Cumberland, PA
See More Headlines
Receive CPIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cumberland Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/10/2021
Today
3/02/2024
Next Earnings (Estimated)
3/05/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:CPIX
CUSIP
23077010
Employees
85
Year Founded
1999

Profitability

Net Income
$-5,570,000.00
Pretax Margin
-6.15%

Debt

Sales & Book Value

Annual Sales
$42.01 million
Cash Flow
$0.47 per share
Book Value
$2.45 per share

Miscellaneous

Free Float
8,634,000
Market Cap
$31.59 million
Optionable
Optionable
Beta
0.19

Social Links

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. A. J. Kazimi MBA (Age 66)
    Founder, Chairman, President & CEO
    Comp: $897.5k
  • Mr. John Michael Hamm (Age 68)
    Chief Financial Officer
    Comp: $231.38k
  • Mr. James Lowrance Herman (Age 69)
    Executive VP of National Accounts & Chief Compliance Officer
    Comp: $352.65k
  • Ms. Jean W. Marstiller (Age 74)
    Senior VP of Administrative Services & Corporate Secretary
    Comp: $282.17k
  • Mr. Chris T. Bitterman (Age 59)
    Vice President of Sales & Marketing
  • Mr. Adam S. Mostafa (Age 43)
    Managing Director
  • Mr. Todd M. Anthony (Age 63)
    Vice President of Organizational Development
  • Ms. Erin Smith Gull
    Senior Corporate Relations Associate














CPIX Stock Analysis - Frequently Asked Questions

How have CPIX shares performed in 2024?

Cumberland Pharmaceuticals' stock was trading at $1.7917 at the start of the year. Since then, CPIX shares have increased by 18.3% and is now trading at $2.12.
View the best growth stocks for 2024 here
.

Are investors shorting Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals saw a drop in short interest in February. As of February 15th, there was short interest totaling 28,700 shares, a drop of 10.3% from the January 31st total of 32,000 shares. Based on an average daily trading volume, of 11,900 shares, the short-interest ratio is presently 2.4 days. Currently, 0.3% of the company's shares are short sold.
View Cumberland Pharmaceuticals' Short Interest
.

When is Cumberland Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 5th 2024.
View our CPIX earnings forecast
.

How were Cumberland Pharmaceuticals' earnings last quarter?

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) issued its earnings results on Tuesday, August, 10th. The specialty pharmaceutical company reported $0.08 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.09) by $0.17. The specialty pharmaceutical company earned $9.06 million during the quarter, compared to analysts' expectations of $8.57 million. Cumberland Pharmaceuticals had a negative net margin of 6.17% and a positive trailing twelve-month return on equity of 8.68%.

What is A. J. Kazimi's approval rating as Cumberland Pharmaceuticals' CEO?

9 employees have rated Cumberland Pharmaceuticals Chief Executive Officer A. J. Kazimi on Glassdoor.com. A. J. Kazimi has an approval rating of 9% among the company's employees. This puts A. J. Kazimi in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Cumberland Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cumberland Pharmaceuticals investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), CymaBay Therapeutics (CBAY), Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), VBI Vaccines (VBIV), Akero Therapeutics (AKRO), Cerecor (CERC), Xeris Biopharma (XERS).

Who are Cumberland Pharmaceuticals' major shareholders?

Cumberland Pharmaceuticals' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Dimensional Fund Advisors LP (2.46%), Citadel Advisors LLC (0.00%), Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include A J Kazimi, A J Kazimi, Caroline Young, James Jones, Joseph C Galante, Kenneth Krogulski, Martin E Cearnal, Martin E Cearnal and William Sumas.
View institutional ownership trends
.

How do I buy shares of Cumberland Pharmaceuticals?

Shares of CPIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CPIX) was last updated on 3/3/2024 by MarketBeat.com Staff